Qingdao Baheal Medical Inc
SZSE:301015
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Qingdao Baheal Medical Inc
Other Long-Term Assets
Qingdao Baheal Medical Inc
Other Long-Term Assets Peer Comparison
1099
601607
600998
000963
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
Q
|
Qingdao Baheal Medical Inc
SZSE:301015
|
Other Long-Term Assets
¥80m
|
CAGR 3-Years
15%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Other Long-Term Assets
¥5.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Other Long-Term Assets
¥2.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
16%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Other Long-Term Assets
¥606.7m
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
31%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Other Long-Term Assets
¥830.1m
|
CAGR 3-Years
55%
|
CAGR 5-Years
34%
|
CAGR 10-Years
18%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Other Long-Term Assets
¥1.7B
|
CAGR 3-Years
16%
|
CAGR 5-Years
22%
|
CAGR 10-Years
38%
|
See Also
What is Qingdao Baheal Medical Inc's Other Long-Term Assets?
Other Long-Term Assets
80m
CNY
Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Other Long-Term Assets amounts to 80m CNY.
What is Qingdao Baheal Medical Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
1%
Over the last year, the Other Long-Term Assets growth was 79%. The average annual Other Long-Term Assets growth rates for Qingdao Baheal Medical Inc have been 15% over the past three years , 1% over the past five years .
You don't have any saved screeners yet
